Status:
COMPLETED
Antenatal Micronutrient Supplementation and Infant Survival
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
Bill and Melinda Gates Foundation
United States Agency for International Development (USAID)
Conditions:
Infant Mortality
Preterm Birth
Eligibility:
FEMALE
12-45 years
Phase:
PHASE3
Brief Summary
The purpose of this community-based randomized trial is to examine whether a daily antenatal and postnatal multiple micronutrient supplement given to women will enhance newborn and infant survival and...
Detailed Description
Maternal deficiency in multiple essential micronutrients is likely to be a major public health problem in low-income countries. Supplementing mothers with certain individual micronutrients has been sh...
Eligibility Criteria
Inclusion
- Pregnant and consents to participate
Exclusion
- Not interviewed for consent within 12 consecutive weeks after being ascertained as pregnant by urine testing
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
44567 Patients enrolled
Trial Details
Trial ID
NCT00860470
Start Date
January 1 2008
End Date
September 1 2012
Last Update
October 19 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins School of Public Health
Baltimore, Maryland, United States, 21205
2
JiVitA Project Office
Rangpur City, Gaibandha District, Bangladesh